IP Library › Granted Patent US 9,695,171
Granted Patent B2
US 9,695,171 · App. 15/104,659 · Granted Jul 4, 2017

3,4-disubstituted-1 H-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7H-pyrrolo[2,3-c]pyridazines as LRRK2 inhibitors

Inventors: Paul Galatsis (Newton, MA); Matthew Merrill Hayward (Old Lyme, CT); Bethany Lyn Kormos (Somerville, MA); Travis T. Wager (Brookline, MA); Lei Zhang (Auburndale, MA); Jaclyn Louise Henderson (Cambridge, MA); Ravi G. Kurumbail (East Lyme, CT); Patrick Robert Verhoest (Newton, MA); Antonia Friederike Stepan (Cambrdige, MA)
Assignee: Pfizer Inc.
C07D471/04C07D487/04C07D491/08C07D498/08C07D519/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,695,171
App. No.
15/104,659
Granted
Jul 4, 2017
Kind
B2
Abstract

The present invention provides novel 3,4-disubstituted-1H-pyrrolo[2,3-b]pyridine derivatives and 4,5-disubstituted-7H-pyrrolo[2,3-c]pyridazine derivatives of Formula I, and the pharmaceutically acceptable salts thereof wherein R 1 , R 2 , R 3 , R 4 and X are as defined in the specification. The invention is also directed to pharmaceutical compositions comprising the compounds of formula I and to use of the compounds in the treatment of diseases associated with LRRK2, such as neurodegenerative diseases including Parkinson's disease or Alzheimer's disease, cancer, Crohn's disease or leprosy.

Claims (151)

1. A compound selected from the group consisting of:

3-[4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]benzonitrile;

2-fluoro-3-[4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]benzonitrile;

3-[4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]imidazo[1,2-b]pyridazine;

1-methyl-4-[4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2-carbonitrile;

1-methyl-4-[4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-imidazole-2-carbonitrile;

1-methyl-4-[4-(morpholin-4-yl)-7H-pyrrolo[2,3-c]pyridazin-5-yl]-1H-pyrrole-2-carbonitrile;

4-[2-chloro-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1-methyl-1H-pyrrole-2-carbonitrile;

3-[2-methyl-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]benzonitrile;

3-[6-methyl-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]benzonitrile;

3-[5-(hydroxymethyl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]benzonitrile;

3-(3-cyanophenyl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile;

4-(3,6-dihydro-2H-pyran-4-yl)-3-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine;

3-(1-methyl-1H-pyrazol-4-yl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine;

3-(3-cyano-2-fluorophenyl)-4-(dimethylamino)-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile;

3-(5-fluoro-2-methoxyphenyl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine;

3-(3-fluoro-5-methoxyphenyl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine;

2-methyl-3-(1-methyl-1H-pyrazol-4-yl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine;

2-fluoro-3-[6-methyl-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]benzonitrile;

6-[4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]pyridine-2-carbonitrile;

3-(3-chlorophenyl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine;

3-(3-chloro-5-fluorophenyl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine;

3-(2,5-difluorophenyl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine;

3-(2-chlorophenyl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine;

3-(2,3-difluorophenyl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine;

3-(3-fluorophenyl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine;

3-(2-fluorophenyl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine;

3-(5-chloro-2-fluorophenyl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine;

{3-[4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]phenyl}methanol;

{4-fluoro-3-[4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]phenyl}methanol;

3-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine;

3-(3-methoxyphenyl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine;

3-(3-chloro-2-fluorophenyl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine;

4-(morpholin-4-yl)-3-(2,3,5-trifluorophenyl)-1H-pyrrolo[2,3-b]pyridine;

3-(3,5-difluorophenyl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine;

3-(2-chloropyridin-3-yl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine;

4-(morpholin-4-yl)-3-phenyl-1H-pyrrolo[2,3-b]pyridine;

3-(2,4-difluorophenyl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine;

3-(3-fluoro-5-methylphenyl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine;

3-fluoro-5-[4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]benzonitrile;

3-(2,3-difluoro-6-methoxyphenyl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine;

2-fluoro-5-[4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]benzonitrile;

3-(5-methoxypyridin-3-yl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine;

6-[2-methyl-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]pyridine-2-carbonitrile;

3-(1-methyl-1H-pyrazol-4-yl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile;

3-(3-cyano-2-fluorophenyl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile;

3-(3-fluoro-5-methylphenyl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile;

4-fluoro-3-[4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]benzonitrile;

3-fluoro-4-[4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]benzonitrile;

3-(hydroxymethyl)-5-[4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]benzonitrile;

3-(4-fluorophenyl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine;

2-methyl-3-(5-methylpyridin-3-yl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine;

3-(3-chlorophenyl)-2-methyl-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine;

2-methyl-4-(morpholin-4-yl)-3-phenyl-1H-pyrrolo[2,3-b]pyridine;

3-(2-fluorophenyl)-2-methyl-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine;

3-(3-fluorophenyl)-2-methyl-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine;

3-fluoro-5-[2-methyl-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]benzonitrile;

1-[3-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridin-4-yl]piperidin-3-ol;

4-[(2S)-2-methylmorpholin-4-yl]-3-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine;

4-(3,3-difluoropiperidin-1-yl)-3-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine;

{1-[3-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridin-4-yl]piperidin-3-yl}methanol;

3-(1-methyl-1H-pyrazol-4-yl)-4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1H-pyrrolo[2,3-b]pyridine;

N,N-dimethyl-3-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridin-4-amine;

3-(1-methyl-1H-pyrazol-4-yl)-4-(thiomorpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine;

4-(3,3-difluoropyrrolidin-1-yl)-3-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine;

3-[4-(3,6-dihydro-2H-pyran-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]benzonitrile;

3-[4-(3-hydroxypiperidin-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]benzonitrile;

3-{4-[2-(methoxymethyl)morpholin-4-yl]-1H-pyrrolo[2,3-b]pyridin-3-yl}benzonitrile;

4-(morpholin-4-yl)-3-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine;

3-[4-(1,4-oxazepan-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]benzonitrile;

3-[4-(4-hydroxypiperidin-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]benzonitrile;

3-[4-(3-methoxypiperidin-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]benzonitrile;

3-[4-(6-oxa-3-azabicyclo[3.1.1]hept-3-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]benzonitrile;

3-{4-[(3R,4R)-3,4-difluoropyrrolidin-1-yl]-1H-pyrrolo[2,3-b]pyridin-3-yl}benzonitrile;

3-[4-(4-fluoropiperidin-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]benzonitrile;

3-{4-[(3R)-3-fluoropyrrolidin-1-yl]-1H-pyrrolo[2,3-b]pyridin-3-yl}benzonitrile;

3-{4-[(2R)-2-methylmorpholin-4-yl]-1H-pyrrolo[2,3-b]pyridin-3-yl}benzonitrile;

3-[4-(pyrrolidin-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]benzonitrile;

3-{4-[(3S)-3-fluoropyrrolidin-1-yl]-1H-pyrrolo[2,3-b]pyridin-3-yl}benzonitrile;

3-[4-(3,3-difluoropiperidin-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]benzonitrile;

3-{4-[(2S)-2-methylmorpholin-4-yl]-1H-pyrrolo[2,3-b]pyridin-3-yl}benzonitrile;

4-[4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]pyridin-2(1H)-one;

methyl 3-(3-cyanophenyl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine-5-carboxylate;

3-[5-(cyanomethyl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]benzonitrile;

3-[5-(methoxymethyl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]benzonitrile;

1-methyl-4-[4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2-carboxamide;

4-[4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2-carbonitrile;

1-methyl-4-[2-methyl-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2-carbonitrile;

3-[4-(pyridin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]benzonitrile;

3-(1-methyl-1H-pyrazol-4-yl)-4-phenyl-1H-pyrrolo[2,3-b]pyridine;

3-[4-(morpholin-4-yl)-7H-pyrrolo[2,3-c]pyridazin-5-yl]benzonitrile;

3-[3-(3-cyanophenyl)-1H-pyrrolo[2,3-b]pyridin-4-yl]-N-cyclopropylbenzamide;

2-fluoro-3-[4-(morpholin-4-yl)-7H-pyrrolo[2,3-c]pyridazin-5-yl]benzonitrile;

3-[4-(pyridin-3-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]benzonitrile;

4-(3,4-difluorophenyl)-3-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine;

4-(2,5-difluorophenyl)-3-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine;

4-(2,3-difluorophenyl)-3-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine;

4-(3-chlorophenyl)-3-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine;

4-(2-fluoro-3-methoxyphenyl)-3-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine;

3-[3-(3-cyanophenyl)-1H-pyrrolo[2,3-b]pyridin-4-yl]-N-methylbenzenesulfonamide;

4-cyclopropyl-3-(2,3-difluoro-6-methoxyphenyl)-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile;

3-[4-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]benzonitrile;

3-(1-methyl-1H-pyrazol-4-yl)-4-(pyridin-4-yl)-1H-pyrrolo[2,3-b]pyridine;

4-(3,5-difluorophenyl)-3-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine;

4-(3-fluoro-4-methoxyphenyl)-3-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine;

4-(2-fluoro-4-methoxyphenyl)-3-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine;

4-(furan-3-yl)-3-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine;

5-[3-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridin-4-yl]-1,3-benzothiazole;

{3-[3-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridin-4-yl]phenyl}acetonitrile;

3-[3-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridin-4-yl]benzonitrile;

5-(1-methyl-1H-pyrazol-4-yl)-4-(morpholin-4-yl)-7H-pyrrolo[2,3-c]pyridazine;

4-[3-(m ethoxymethyl)phenyl]-3-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine; and

3-{4-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-pyrrolo[2,3-b]pyridin-3-yl}benzonitrile;

or a pharmaceutically acceptable salt thereof.

2. A compound selected from the group consisting of:

3-[4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]benzonitrile;

2-fluoro-3-[4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]benzonitrile;

3-[4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]imidazo[1,2-b]pyridazine;

1-methyl-4-[4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2-carbonitrile;

1-methyl-4-[4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-imidazole-2-carbonitrile;

1-methyl-4-[4-(morpholin-4-yl)-7H-pyrrolo[2,3-c]pyridazin-5-yl]-1H-pyrrole-2-carbonitrile;

4-[2-chloro-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1-methyl-1H-pyrrole-2-carbonitrile;

3-(3-cyanophenyl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile;

3-(1-methyl-1H-pyrazol-4-yl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine;

3-(3-cyano-2-fluorophenyl)-4-(dimethylamino)-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile;

3-(2,3-difluorophenyl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine;

3-(2-fluorophenyl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine;

3-(3-fluoro-5-methylphenyl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine;

3-(3-cyano-2-fluorophenyl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile;

3-(3-fluoro-5-methylphenyl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile;

3-[4-(3,6-dihydro-2H-pyran-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]benzonitrile;

3-[4-(3-hydroxypiperidin-1-yl)-1H-pyrrolo[2, 3-b]pyridin-3-yl]benzonitrile;

3-[4-(pyrrolidin-1-yl)-1H-pyrrolo[2, 3-b]pyridin-3-yl]benzonitrile;

3-{4-[(3S)-3-fluoropyrrolidin-1-yl]-1H-pyrrolo[2,3-b]pyridin-3-yl}benzonitrile;

3-{4-[(2S)-2-methylmorpholin-4-yl]-1H-pyrrolo[2,3-b]pyridin-3-yl}benzonitrile;

4-[4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]pyridin-2(1H)-one;

methyl 3-(3-cyanophenyl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine-5-carboxylate;

1-methyl-4-[4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2-carboxamide;

4-[4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2-carbonitrile;

1-methyl-4-[2-methyl-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2-carbonitrile;

3-[4-(pyridin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]benzonitrile; and

3-(1-methyl-1H-pyrazol-4-yl)-4-phenyl-1H-pyrrolo[2,3-b]pyridine;

or a pharmaceutically acceptable salt thereof.

3. A compound selected from the group consisting of

3-[4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]benzonitrile;

1-methyl-4-[4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2-carbonitrile; and 3-(1-methyl-1H-pyrazol-4-yl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine;

or a pharmaceutically acceptable salt thereof.

4. The compound of claim 3 which is 3-[4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]benzonitrile, or a pharmaceutically acceptable salt thereof.

5. The compound of claim 3 which is 1-methyl-4-[4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2-carbonitrile, or a pharmaceutically acceptable salt thereof.

6. The compound of claim 3 which is 3-(1-methyl-1H-pyrazol-4-yl)-4-(morpholin-4-yl)-1H-pyrrolo[2,3-b]pyridine, or a pharmaceutically acceptable salt thereof.

7. A pharmaceutical composition comprising a therapeutically effective amount of a compound according to claim 1 , or a pharmaceutically acceptable salt thereof together with a pharmaceutically acceptable carrier.

Continuity (2)
Provisional Application 61916953 · Dec 17, 2013
Related Publication 20170002000A1 · Jan 5, 2017